Medscape

New safety label for Cordarone IV recognizes dangers of off-label pediatric use

Philadelphia, PA - Wyeth-Ayerst Pharmaceuticals have issued a letter alerting healthcare professionals to two dangers of Cordarone IV® (amiodarone HCL) use in pediatric patients, and detailing related ...
Monthly Prescribing Reference

Patient Develops Acute Liver Failure Following Amiodarone Infusion

HealthDay News — In a report published online July 16 in the Journal of Clinical Pharmacy and Therapeutics, a case of survival after acute liver failure secondary to amiodarone administration is ...
Medscape

Plastic-friendly IV amiodarone preparation gets FDA approval

King of Prussia, PA - The FDA has approved a novel formulation of amiodarone hydrochloride for intravenous (IV) use (Nexterone injection) that doesn't include polysorbate 80 or benzyl alcohol, ...
FierceBiotech

Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachyc

KING OF PRUSSIA, Pa., Jan. 5 /PRNewswire/ -- Prism Pharmaceuticals announced today that the U.S. Food & Drug Administration (FDA) has approved the new drug application (NDA) for NEXTERONE(R) ...
Medindia

Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use NEXTERONE® (amiodarone HCl) Premixed Injection

KING OF PRUSSIA, Pa., Nov. 18, 2010 /PRNewswire/ -- Prism Pharmaceuticals, Inc. announced today that the U.S. Food & Drug Administration (FDA) has approved the supplemental new drug application for ...
Monthly Prescribing Reference

Label Mix-Up Prompts Recall of IV Amiodarone, Tranexamic Acid

Inadvertent administration may result in serious adverse events. Mylan announced the voluntary recall to the hospital/clinic level of 4 lots of Amiodarone HCl Injection, USP 450mg/9mL and Tranexamic ...
Healio

Amiodarone Topic Review

Amiodarone is a class III antiarrhythmic drug, with some class IA properties. Amiodarone on rare occasions can induce torsades de pointes within the first 48 hours of intravenous administration, even ...
Healio

The current status of amiodarone adverse event monitoring

Amiodarone was discovered in 1961, but was not approved by the FDA until 1985. Although classified as a class III antiarrhythmic, amiodarone exhibits properties of class I, II and IV antiarrhythmics ...
ABC News

What Is Amiodarone, How Does It Work, And What Are The Risks/Side Effects?

Dr. Naccarelli answers the question: 'What Is Amiodarone, How Does It Work?' — -- Question: I have been placed on an antiarrhythmic drug called amiodarone for my heart rhythm problem. How does it ...
Nature

AVRO—were the results a surprise?

Multiple placebo-controlled trials have demonstrated that intravenous vernakalant, a novel antiarrhythmic agent, effectively converts recent-onset atrial fibrillation in ∼50% of patients within 90 min ...
Medindia

Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia

KING OF PRUSSIA, Pa., Jan. 5 Prism Pharmaceuticalsannounced today that the U.S. Food & Drug Administration (FDA) has approvedthe new drug application (NDA) for NEXTERONE(R) (amiodarone HCl) Injection, ...